MagnetisMM-20
A Clinical Trial of Four Medicines (Elranatamab Plus Carfilzomib and Dexamethasone or Maplirpacept) in People With Relapsed Refractory Multiple Myeloma
Arms / Cohorts
Experimental: Dose Escalation:Part 1: Elranatamab, Carfilzomib and Dexamethasone
Accepting patients
Experimental:Part 2A: Elranatamab and Maplirpacept
Accepting patients
Experimental, Dose Randomization:Part 2B: Elranatamab and Maplirpacept
Accepting patients
Real People. Real Support.
Need help connecting with this clinical trial? We're here to help!
Print a patient-friendly report to share with your patient.
We can help answer any questions and connect you (or your patient) with the study team.
Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.